Watertown, Mass, January 9, 2023 – In a significant development in the healthcare sector, Exergen Corporation, a pioneer in non-invasive thermometry, has joined forces with SKH Comercial e Inversiones SpA, a leading healthcare marketing and communication provider in Chile. This collaboration marks the introduction of the advanced Exergen Temporal Artery Thermometer TAT-2000C to the Chilean market.
The partnership agreement, signed by Mrs. Sandra Katherine Hernández Urrea of SKH Comercial e Inversiones and Dr. Francesco Pompei of Exergen Corporation, outlines a comprehensive strategy to enhance Chilean healthcare services. Key initiatives include a dynamic 360º marketing campaign, direct engagement with medical professionals through monthly visits to major clinics, active management of the @exergen_chile Instagram account, and a targeted influencer campaign on social media platforms all which will lead consumers to learn about the best technology and buy it at the largest pharmacy chains in Chile.
The Exergen Temporal Artery Thermometer TAT-2000C is renowned for its exceptional accuracy, rapid measurement capability (within 2-3 seconds), affordability, durability, and easy maintenance. With extensive clinical validation, this thermometer is an epitome of patient safety and convenience. It is especially relevant in today’s health-conscious environment, where regular monitoring of body temperature is crucial for early detection of health concerns.
Given the current global health landscape, the importance of reliable and efficient temperature monitoring cannot be overstated. The Exergen Temporal Artery Thermometer offers a non-invasive, accurate method to track body temperature, making it an indispensable tool for both medical professionals and individuals. In times where health vigilance is paramount, the TAT-2000C serves as a beacon of innovation and reliability for consumers.
This partnership between Exergen Corporation and SKH Comercial e Inversiones SpA is more than a business venture. It represents a commitment to enhancing healthcare services in Chile. The introduction of the Exergen TAT-2000C Temporal Artery Thermometers into the Chilean market signifies a new era in healthcare, where advanced medical tools become more accessible, ensuring better health outcomes and elevating the standard of care.
Exergen Corporation, the leader in non-invasive temperature measurement technologies for industrial and medical applications, delivers non-invasive temperature meters at lower costs, with higher accuracy, less process control and higher reliability than previously possible. With its award-winning arterial thermometer, Exergen is known in both the healthcare and consumer markets. The company was founded by MIT educated and Harvard researcher Dr. Francesco Pompei, who owns more than 70 patents. Exergen Corporation is headquartered in Watertown, Massachusetts, United States.
Senior International Communications Manager
EXERGEN P/N 850126